循環腫瘍細胞（CTC）診断の世界市場は、2021年の88億ドルから、2026年までに152億ドルに拡大し、2021年から2026年までのCAGRは15.6％と推定されます。
目次
Chapter- 1: Introduction
Study Background
Study Goals and Objectives
Reasons for Doing this Study
Scope of Report
What's New in this Update?
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter- 2: Summary and Highlights
Table Summary : Global Market for Circulating Tumor Cells (CTC) Diagnostics, by Cancer Type, Through 2026
Figure Summary : Global Market Shares of Circulating Tumor Cells (CTC) Diagnostics, by Cancer Type, 2020
Chapter- 3: Market and Technology Background
Cancer
Circulating Tumor Cells
Metastatic Development in Cancer Patients
Methods
Chapter- 4: CTC Diagnostic Technologies
Finding Circulating Tumor Cells
Chapter- 5: Impact of COVID-19 on the CTC Diagnostics Market
Overview
COVID-19 and Cancer Screening
Impact of COVID-19 on Company Revenues
Chapter- 6: Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Competitive Landscape
Chapter- 7: Market Breakdown by Cancer Type
Global Market for CTC Diagnostics by Cancer Type
Chapter- 8: Market Breakdown by Technology
Global Market for CTC Diagnostics by Technology
Chapter- 9: Market Breakdown by Application
Global Market for CTC Diagnostics by Application
Chapter- 10: Market Breakdown by Region
Global Market for CTC Diagnostics by Region
Chapter- 11: Company Profiles
BIO-TECHNE CORP. (ADVANCED CELL DIAGNOSTICS INC.)
BIOCEPT, INC.
BIOFLUIDICA
CREATV MICROTECH INC.
FLUXION BIOSCIENCES, INC.
GREINER BIO-ONE INTERNATIONAL GMBH
IKONISYS, INC.
IVDIAGNOSTICS, INC.
MENARINI SILICON BIOSYSTEMS (FORMERLY VERIDEX LLC)
MILTENYI BIOTEC
PRECISION MEDICINE GROUP LLC
QIAGEN N.V.
RARECELLS, INC.
SCREENCELL
STEMCELL TECHNOLOGIES INC.
Chapter- 12: Appendix: List of Acronyms
Table 71 : Commonly Used Acronyms in the Market for CTC Diagnostics
